Prognostic Value of Structural and Functional Microvascular Dysfunction in Patients with Nonobstructive Coronary Artery Disease

Coronary microvascular dysfunction (CMD) is a paramount factor involved in the development of anginal syndromes. Among patients with angina and nonobstructive coronary artery disease with CMD, two patterns have been identified using minimal microvascular resistance: structural CMD, and functional CMD.

Valor pronóstico de disfunción microvascular estructural y funcional en pacientes con enfermedad coronaria no obstructiva

Structural CMD is characterized by decreased coronary flow reserve (CFR) in the presence of increased microvascular resistance. This subtype represents changes in the microvasculature such as arteriolar obliteration, which improves under conditions of maximal vasodilatation.

However, functional CMD is characterized by decreased CFR with normal or decreased microvascular resistance. This is related to increased myocardial oxygen demand or impaired coronary autoregulation. However, the prognostic relevance of these two CMD subtypes has not been evaluated.

The aim of this (multicenter, retrospective) ILIAS Registry was to evaluate the prognostic impact of structural vs. functional CMD in patients with nonobstructive coronary artery disease.

This study analyzed 1102 patients. Mean patient age was 63 years old, and 69% of subjects were male. The most analyzed artery was the anterior descending artery, followed by the circumflex artery. Patients were classified into four groups based on CFR (cutoff value <2.5), and two groups based on microvascular resistance: low and high (in terms of the microvascular resistance index [MRI] and the hyperemic microvascular resistance [HMR]).

Read also: Complicated Non-Stenotic Carotid Plaques: A Light in the Diagnosis of Cryptogenic Stroke?

Regarding the results, abnormal CFR values were associated with increased risk of MACE and treated vessel failure (TVF) at 5 years regardless of the values of microvascular resistance obtained. However, abnormal microvascular resistance values were not associated with increased MACE and TVF. Lastly, there were no differences between normal or abnormal microvascular resistance values in patients with normal CFR.

Conclusion

CMD, represented as a decrease in CFR, was associated with an increase in MACE and FVL at a 5-year follow-up. In contrast, microvascular resistance was not associated with adverse clinical events. In patients with CMD, there were no significant differences in MACE and TVF between structural CMD and functional CMD.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member o the Editorial Board of SOLACI.org.

Original Title: Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry.

Reference: Coen K.M. Boerhout et al EuroIntervention 2022;18.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...